Clinical Trials
135 trialsPIPACOVA
Hospices Civils de Lyon
MARACAS
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Safety and Efficacy of PIPAC Using Single Agent Mitomycin in Solid Tumors
H. Lee Moffitt Cancer Center and Research Institute
Technical Feasibility of Modified Early Post-Operative Intraperitoneal Chemotherapy (mEPIC)
Ciusss de L'Est de l'Île de Montréal
Surgery and Heated Intraperitoneal Chemotherapy for Adrenocortical Carcinoma
Columbia University
Peritoneal Carcinomatosis Leveraging ctDNA Guided Treatment in GI Cancer Study (PERICLES Study)
Rutgers, The State University of New Jersey
Paclitaxel for the Treatment of Gastric or Gastroesophageal Cancer
M.D. Anderson Cancer Center
ProphyloCHIP
Gustave Roussy, Cancer Campus, Grand Paris
EPICH
Fondazione del Piemonte per l'Oncologia
Flat Dose vs. Weight-based IP Chemotherapy for CRS/HIPEC
University of Kentucky
SurgiPerito Trial: High-Purity Type-I Collagen for Peritoneal Reconstruction After Cytoreductive Surgery
Adichunchanagiri Institute of Medical Sciences, B G Nagara
CAIRO6
Catharina Ziekenhuis Eindhoven
PhI Pilot Study Pafolacianine Inject for Intraoperative Imaging on Outcomes of GI Cancer Peritoneal Carcinomatosis
University of California, Irvine
Charlie-2
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
Intraperitoneal Paclitaxel-loaded TPM for Treatment of Peritoneal Carcinomatosis
University of Iowa
INSIGHT
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
NUCLEAR
Hospices Civils de Lyon
A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer
Memorial Sloan Kettering Cancer Center
MESOTIP
Institut du Cancer de Montpellier - Val d'Aurelle
STOPGAP
University of California, Irvine
Intraperitoneal Paclitaxel With NALIRIFOX for Pancreatic Ductal Adenocarcinoma With Peritoneal Carcinomatosis
University of Colorado, Denver
COCOON
Institut du Cancer de Montpellier - Val d'Aurelle
Treatment of Primary Peritoneal Carcinosis of Digestive Origin Using Cytoreductive Surgery and Hyperthermic Intraoperative Peritoneal Chemotherapy With Mitomycin C and Irinotecan
Hospices Civils de Lyon
BIG-RENAPE
Hospices Civils de Lyon
PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer
City of Hope Medical Center
Tolerance, Safety, Efficacy, and Pharmacokinetics of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Using Paclitaxel for Platinum-resistant Recurrent Ovarian Cancer
Seoul National University Hospital
ALBUCHIP
Assistance Publique - Hôpitaux de Paris
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
University of Chicago
PIPAC and FOLFOX for Gastric Cancer Peritoneal Cancer
Vilnius University
COCHISE
Institut Bergonié
PROPAC
University Hospital, Geneva
Patient Derived Vascularized MicroTumor Model of Gastrointestinal Peritoneal Carcinomatosis
University of California, Irvine
PIPADN
Institut de Cancérologie de Lorraine
PERISCOPEII
The Netherlands Cancer Institute
PIPAC-NAL-IRI
University Hospital, Ghent
RCT of Two Noncrosslinked Porcine Acellular Dermal Matrices in Ab Wall Reconstruction
Ohio State University
PARP-inhibition and CTLA-4 Blockade in BRCA-deficient Ovarian Cancer
New Mexico Cancer Research Alliance
Nivolumab With or Without Ipilimumab in Treating Patients With Recurrent or High Grade Gynecologic Cancer With Metastatic Peritoneal Carcinomatosis
M.D. Anderson Cancer Center
Preventive Use of PIPAC in Locally Advanced Gastric Cancer.
National Research Oncology and Transplantology Center, Kazakhstan
FAPeCa
Jules Bordet Institute
DWI-PDAC
Laval University
DWI-HighRisk
Laval University
BCBOvaire
Institut du Cancer de Montpellier - Val d'Aurelle
MicroFluO
Assistance Publique - Hôpitaux de Paris
TEMPO
Duke University
HIPEC for Peritoneal Carcinomatosis
Albert Einstein College of Medicine
GECOP-MMC
Hospital Universitario de Fuenlabrada
Heated Mitomycin and Cisplatin During Surgery in Treating Patients With Stomach or Gastroesophageal Cancer
M.D. Anderson Cancer Center
Intraperitoneal Docetaxel in Combination With mFOLFOX6 for Gastric Cancer Patients With Peritoneal Carcinomatosis
Johns Hopkins University
Galunisertib Combined With Capecitabine in Advanced CRC With PM
The Netherlands Cancer Institute